Liver Fibrosis Quantification and Analysis: The LiQA Dataset and Baseline Method

arXiv ID: 2512.07651v1

Published: 2025-12-08

Authors: Yuanye Liu, Hanxiao Zhang, Nannan Shi, Yuxin Shi, Arif Mahmood, Murtaza Taj, Xiahai Zhuang

Categories: cs.CV

Relevance Score: 1.00 / 1.00

View on arXiv Download PDF

Summary

This paper introduces the LiQA (Liver Fibrosis Quantification and Analysis) dataset, a multi-phase, multi-center MRI dataset from 440 patients, designed to benchmark algorithms for liver segmentation (LiSeg) and fibrosis staging (LiFS) amidst real-world complexities like domain shifts and missing data. It also details a top-performing baseline method that uses semi-supervised learning and a multi-view consensus approach, demonstrating improved robustness in clinical settings through leveraging multi-source data and anatomical constraints.

Medical Relevance

Accurate and automated staging of liver fibrosis is crucial for timely diagnosis, prognosis, and effective clinical management of patients, reducing the need for invasive biopsies and improving treatment outcomes.

AI Health Application

The paper describes the development and evaluation of AI algorithms for automated segmentation of the liver and automated staging of liver fibrosis from multi-phase, multi-center MRI scans. These AI applications aim to assist clinicians in the diagnosis, monitoring, and management of liver fibrosis, improving accuracy and efficiency in clinical settings.

Key Points

Introduces the LiQA (Liver Fibrosis Quantification and Analysis) dataset, comprising 440 multi-phase, multi-center MRI scans for liver fibrosis research.
The dataset is specifically curated to benchmark algorithms for Liver Segmentation (LiSeg) and Liver Fibrosis Staging (LiFS) under challenging real-world conditions.
Challenges addressed by the dataset include domain shifts, missing imaging modalities, and spatial misalignment between scans.
The baseline segmentation method incorporates a semi-supervised learning framework enhanced with external data for robust performance.
The baseline staging method utilizes a multi-view consensus approach, regularized with Class Activation Maps (CAM) for improved accuracy and interpretability.
Evaluation confirms that integrating multi-source data and anatomical constraints significantly boosts model robustness and accuracy in clinical applications.
The research is part of the CARE 2024 challenge, fostering algorithm development for accurate liver fibrosis assessment.

Methodology

The study establishes the LiQA dataset, comprising MRI scans from 440 patients, designed to test algorithms for Liver Segmentation (LiSeg) and Liver Fibrosis Staging (LiFS) under varied real-world conditions. The proposed baseline methodology for segmentation employs a semi-supervised learning framework augmented with external data. For fibrosis staging, a multi-view consensus approach is used, incorporating Class Activation Map (CAM)-based regularization to enhance model decision-making.

Key Findings

The top-performing baseline method demonstrates that leveraging multi-source data and anatomical constraints significantly enhances model robustness for both liver segmentation and fibrosis staging, even when faced with complex real-world data challenges like domain shifts and missing modalities.

Clinical Impact

This research provides a valuable benchmark dataset and robust methodology that can accelerate the development of automated, non-invasive tools for precise liver fibrosis quantification. This can lead to earlier and more accurate diagnosis, better patient stratification, and optimized treatment strategies, potentially reducing reliance on invasive biopsies.

Limitations

The abstract highlights the inherent complexities of real-world clinical data, such as domain shifts, missing modalities, and spatial misalignment, which the dataset is designed to benchmark against. While the baseline method demonstrates robustness under these conditions, these factors remain significant challenges for generalizability across diverse clinical settings.

Future Directions

Not explicitly detailed in the abstract, but the establishment of the LiQA dataset and the CARE 2024 challenge inherently encourages future research in developing more robust and generalizable AI models for liver fibrosis quantification, particularly those that can overcome the described real-world complexities.

Medical Domains

Hepatology Radiology Gastroenterology

Keywords

Liver Fibrosis MRI Dataset Segmentation Staging Semi-supervised Learning Class Activation Map CARE 2024

Abstract

Liver fibrosis represents a significant global health burden, necessitating accurate staging for effective clinical management. This report introduces the LiQA (Liver Fibrosis Quantification and Analysis) dataset, established as part of the CARE 2024 challenge. Comprising $440$ patients with multi-phase, multi-center MRI scans, the dataset is curated to benchmark algorithms for Liver Segmentation (LiSeg) and Liver Fibrosis Staging (LiFS) under complex real-world conditions, including domain shifts, missing modalities, and spatial misalignment. We further describe the challenge's top-performing methodology, which integrates a semi-supervised learning framework with external data for robust segmentation, and utilizes a multi-view consensus approach with Class Activation Map (CAM)-based regularization for staging. Evaluation of this baseline demonstrates that leveraging multi-source data and anatomical constraints significantly enhances model robustness in clinical settings.